Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
GLUCOSE 10% 50 g/500 mL injection bag, Fresenius Kabi Australia Pty Ltd, CON-202
Product name
GLUCOSE 10% 50 g/500 mL injection bag
Sponsor name
Fresenius Kabi Australia Pty Ltd
Batches
14KK7321
Consent start
Consent no.
CON-202
Standard
Subclause 3(2)(l) of the Therapeutic Goods Order No.69.
Non-compliance with standard
The products do not have the current sponsor address printed on the labels.
Conditions imposed
The labels to which this consent applies are those previously approved where
the product labels bear the former sponsor address and that arrangements are in
place to redirect all mail to the new sponsor address.
Therapeutic product type
Prescription medicines